Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency

Obstetrics and Gynecology

Volumn 101, Issue 5 SUPPL., 2003, Pages 1135-1136

  Bartha, J L ^a   Finning, K ^b   Soothill, P W ^b  

^a ST MICHAEL'S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; CASE REPORT; DNA ISOLATION; FETUS; GESTATIONAL AGE; HUMAN; KARYOTYPE; MALE; MATERNAL BLOOD; MATERNAL PLASMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRENATAL SCREENING; PRIORITY JOURNAL; RISK FACTOR; SEX DETERMINATION; SRY GENE; STEROID 21 MONOOXYGENASE DEFICIENCY; VIRILIZATION; Y CHROMOSOME;

EID: 0037622188     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00064-4     Document Type: Article

References (8)

1. Speiser P.W., Laforgia N., Kato K., Pareira J., Khan R., Yang S.Y., et al. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). J Clin Endocrinol Metab. 70:1990;838-848.
2. Lajic S., Wedell A., Bui T.H., Ritzen E.M., Holst M. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 83:1998;3872-3880.
3. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., et al. Quantitative analysis of fetal DNA in maternal plasma and serum Implications for noninvasive prenatal diagnosis . Am J Hum Genet. 62:1998;768-775.
4. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 350:1997;485-487.
5. Rijnders R.J., van der Schoot E., Bossers B., de Vroede M.A.M.J., Crristiaens G.C.M.L. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol. 98:2001;374-378.
6. Thomas M.R., Tutschek B., Frost A., Rodeck C.H., Yazdani N., Craft I., et al. The time of appearance and disappearance of fetal DNA from the maternal circulation. Prenat Diagn. 15:1995;641-646.
7. Amicucci P., Gennarelli M., Novelli G., Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem. 46:2000;301-302.
8. Saito H., Sekizawa A., Morimoto T., Suzuki M., Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet. 356:2000;1170.